Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer

Skin deposits from breast cancer can present serious therapeutic problems, especially when resistant to conventional therapy. Topical application of a cytotoxic drug may represent an attractive new treatment modality devoid of major systemic toxicity. Miltefosine was selected because of its efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Terwogt, J M M, Mandjes, I A M, Sindermann, H, Beijnen, J H, ten Bokkel Huinink, W W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362219/
https://www.ncbi.nlm.nih.gov/pubmed/10098751
http://dx.doi.org/10.1038/sj.bjc.6690184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362219/
https://www.ncbi.nlm.nih.gov/pubmed/10098751
http://dx.doi.org/10.1038/sj.bjc.6690184

Ejemplares similares